ClearPoint Neuro, Inc. (CLPT)
CLPT Stock Price Chart
Explore ClearPoint Neuro, Inc. interactive price chart. Choose custom timeframes to analyze CLPT price movements and trends.
CLPT Company Profile
Discover essential business fundamentals and corporate details for ClearPoint Neuro, Inc. (CLPT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
22 May 2012
Employees
115.00
Website
https://www.clearpointneuro.comCEO
Joseph Michael Burnett
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
CLPT Financial Timeline
Browse a chronological timeline of ClearPoint Neuro, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.20, while revenue estimate is $9.60M.
Earnings released on 12 Aug 2025
EPS came in at -$0.21 falling short of the estimated -$0.20 by -5.00%, while revenue for the quarter reached $9.22M , missing expectations by -5.97%.
Earnings released on 13 May 2025
EPS came in at -$0.22 falling short of the estimated -$0.15 by -46.67%, while revenue for the quarter reached $8.49M , missing expectations by -7.44%.
Earnings released on 26 Feb 2025
EPS came in at -$0.20 falling short of the estimated -$0.15 by -33.33%, while revenue for the quarter reached $7.77M , missing expectations by -5.57%.
Earnings released on 7 Nov 2024
EPS came in at -$0.18 falling short of the estimated -$0.17 by -5.88%, while revenue for the quarter reached $8.12M , beating expectations by +4.40%.
Earnings released on 7 Aug 2024
EPS came in at -$0.16 surpassing the estimated -$0.19 by +15.79%, while revenue for the quarter reached $7.86M , beating expectations by +7.20%.
Earnings released on 7 May 2024
EPS came in at -$0.16 surpassing the estimated -$0.19 by +15.79%, while revenue for the quarter reached $7.64M , beating expectations by +9.28%.
Earnings released on 12 Mar 2024
EPS came in at -$0.19 surpassing the estimated -$0.22 by +13.64%, while revenue for the quarter reached $6.81M , beating expectations by +4.29%.
Earnings released on 9 Nov 2023
EPS came in at -$0.20 surpassing the estimated -$0.25 by +20.00%, while revenue for the quarter reached $5.76M , missing expectations by -9.26%.
Earnings released on 8 Aug 2023
EPS came in at -$0.29 falling short of the estimated -$0.18 by -61.11%, while revenue for the quarter reached $5.95M , beating expectations by +0.85%.
Earnings released on 11 May 2023
EPS came in at -$0.23 falling short of the estimated -$0.18 by -27.78%, while revenue for the quarter reached $5.43M , beating expectations by +6.53%.
Earnings released on 1 Mar 2023
EPS came in at -$0.18 surpassing the estimated -$0.22 by +18.18%, while revenue for the quarter reached $5.17M , missing expectations by -0.50%.
Earnings released on 8 Nov 2022
EPS came in at -$0.15 surpassing the estimated -$0.19 by +21.05%, while revenue for the quarter reached $5.15M , missing expectations by -4.70%.
Earnings released on 9 Aug 2022
EPS came in at -$0.18 matching the estimated -$0.18, while revenue for the quarter reached $5.20M , beating expectations by +2.32%.
Earnings released on 11 May 2022
EPS came in at -$0.17 surpassing the estimated -$0.20 by +15.00%, while revenue for the quarter reached $5.03M , beating expectations by +20.27%.
Earnings released on 1 Mar 2022
EPS came in at -$0.19 matching the estimated -$0.19, while revenue for the quarter reached $4.28M , missing expectations by -0.42%.
Earnings released on 9 Nov 2021
EPS came in at -$0.18 falling short of the estimated -$0.16 by -12.50%, while revenue for the quarter reached $4.57M , beating expectations by +14.35%.
Earnings released on 10 Aug 2021
EPS came in at -$0.17 falling short of the estimated -$0.14 by -21.43%, while revenue for the quarter reached $3.41M , missing expectations by -7.26%.
Earnings released on 11 May 2021
EPS came in at -$0.13 surpassing the estimated -$0.15 by +13.33%, while revenue for the quarter reached $4.03M , beating expectations by +20.30%.
Earnings released on 4 Mar 2021
EPS came in at -$0.09 surpassing the estimated -$0.13 by +30.77%, while revenue for the quarter reached $3.72M , beating expectations by +12.95%.
Earnings released on 10 Nov 2020
EPS came in at -$0.09 surpassing the estimated -$0.14 by +35.71%, while revenue for the quarter reached $3.52M , missing expectations by -26.32%.
CLPT Stock Performance
Access detailed CLPT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.